BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 1373687)

  • 1. Human interleukin (IL)-9 specifically stimulates proliferation of CD34+++DR+CD33- erythroid progenitors in normal human bone marrow in the absence of serum.
    Lu L; Leemhuis T; Srour EF; Yang YC
    Exp Hematol; 1992 May; 20(4):418-24. PubMed ID: 1373687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence in vitro of IL-3/Epo fusion proteins compared with the combination of IL-3 plus Epo in enhancing the proliferation of single isolated erythroid and multipotential progenitor cells from human umbilical cord blood and adult bone marrow.
    Lu L; Xiao M; Li ZH; Jolliffe LK; Jones S; Broxmeyer HE; Weich N
    Exp Hematol; 1995 Sep; 23(10):1130-4. PubMed ID: 7656932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.
    Ottmann OG; Stella CC; Eder M; Reutzel P; Ströcker S; Hoelzer D; Ganser A
    Exp Hematol; 1991 Sep; 19(8):773-8. PubMed ID: 1714403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
    Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
    Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of IL-1 alpha and -1 beta on the survival of human bone marrow cells responding to hematopoietic colony-stimulating factors.
    Hangoc G; Williams DE; Falkenburg JH; Broxmeyer HE
    J Immunol; 1989 Jun; 142(12):4329-34. PubMed ID: 2656864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of retroviral-mediated gene transduction of both the recombinant human erythropoietin receptor and interleukin-9 receptor genes into single CD34++CD33-or low cord blood cells on cytokine-stimulated erythroid colony formation.
    Lu L; Ge Y; Li ZH; Xiao M; Broxmeyer HE
    Exp Hematol; 1996 Feb; 24(2):347-51. PubMed ID: 8641364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.
    La Russa VF; Griffin JD; Kessler SW; Cutting MA; Knight RD; Blattler WA; Lambert JM; Wright DG
    Exp Hematol; 1992 May; 20(4):442-8. PubMed ID: 1373688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of combinations of cytokines on proliferation of isolated single cell-sorted human bone marrow hematopoietic progenitor cells in the absence and presence of serum.
    Xiao M; Leemhuis T; Broxmeyer HE; Lu L
    Exp Hematol; 1992 Feb; 20(2):276-9. PubMed ID: 1371967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulatory effect of human insulin on erythroid progenitors (CFU-E and BFU-E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin.
    Aoki I; Taniyama M; Toyama K; Homori M; Ishikawa K
    Stem Cells; 1994 May; 12(3):329-38. PubMed ID: 7521243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
    Lu L; Walker D; Broxmeyer HE; Hoffman R; Hu W; Walker E
    J Immunol; 1987 Sep; 139(6):1823-9. PubMed ID: 3114377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of T-lymphocytes and lactoferrin on the survival-promoting effects of IL-1 and IL-6 on human bone marrow granulocyte-macrophage and erythroid progenitor cells.
    Hangoc G; Falkenburg JH; Broxmeyer HE
    Exp Hematol; 1991 Aug; 19(7):697-703. PubMed ID: 1893956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transduction of human interleukin-9 receptor gene into human cord blood erythroid progenitors increases the number of erythropoietin-dependent erythroid colonies.
    Xiao M; Yang YC; Yang L; Chang MS; Cornetta K; Broxymeyer HE; Lu L
    Bone Marrow Transplant; 1996 Dec; 18(6):1103-9. PubMed ID: 8971379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of interleukins 3,5, and 6 on the growth of eosinophil progenitors in highly enriched human bone marrow in the absence of serum.
    Lu L; Lin ZH; Shen RN; Warren DJ; Leemhuis T; Broxmeyer HE
    Exp Hematol; 1990 Dec; 18(11):1180-6. PubMed ID: 1699774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
    Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE
    Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mast cell growth factor, interleukin-3, and interleukin-6 on human primitive hematopoietic progenitors from bone marrow and cord blood.
    Tsujino Y; Wada H; Misawa M; Kai S; Hara H
    Exp Hematol; 1993 Sep; 21(10):1379-86. PubMed ID: 7689484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rhIL-1 alpha, rhIL-1 beta, and rhIL-1 receptor antagonist on erythroid progenitors (CFU-E and BFU-E) in human bone marrow.
    Aoki I; Homori M; Nakahara K; Higashi K; Ishikawa K
    Exp Hematol; 1995 Mar; 23(3):217-25. PubMed ID: 7533099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant murine interleukin 9 enhances the erythropoietin-dependent colony formation of human BFU-E.
    Birner A; Hültner L; Mergenthaler HG; van Snick J; Dörmer P
    Exp Hematol; 1992 Jun; 20(5):541-5. PubMed ID: 1587301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.